Education
About Us
Working with TipRanks
Follow Us
Rapid Micro Biosystems (RPID)
NASDAQ:RPID
RPID Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.58 - $4.04
Previous CloseN/A
Volume19.55K
Average Volume (3M)689.38K
Market Cap
$114.14M
Enterprise Value-$5.17M
Total Cash (Recent Filing)-$12.61M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.92
Next Earnings
May 02, 2025EPS Estimate
-0.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.08
Shares Outstanding38,737,160
10 Day Avg. Volume188,017
30 Day Avg. Volume689,376
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)3.99
Price to Cash Flow (P/CF)-2.80
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.05
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit0.94
Enterprise Value/Ebitda0.11
Forecast
1Y Price Target
$8.00Price Target Upside206.51% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
---
Rapid Micro Biosystems News
PremiumCompany Announcements
Rapid Micro Biosystems Updates Strategic Priorities for 2025
PremiumCompany Announcements
Rapid Micro Biosystems’ Earnings Call Reveals Mixed Sentiment
PremiumCompany Announcements
Rapid Micro Biosystems Reports Strong 2024 Financial Growth
PremiumCompany Announcements
Rapid Micro Biosystems Partners with MilliporeSigma for Global Expansion
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceQ3 revs of $7.6M beat prior guidance and hit a record-high for the company, driven by outperforming product revenues.
Product AdoptionRPID's system has 164 installations and is used by 70% of the top 20 biopharmas and Lonza, validating its acceptance and effectiveness in the market.
Revenue GrowthThe company is gaining wide adoption in the biopharmaceutical industry, with a 28% revenue growth from 2022-2024, leading to increased top-line visibility and improving margins.
Bears Say
Dependence On Major CustomersRecord high Q3 revs driven by a multi-system order from existing Top 20 pharma may indicate a heavy reliance on a limited number of significant clients.
Market CompetitionRapid Micro Bio's Microbial Growth Direct System is changing the paradigm in biological manufacturing quality control, but the company faces competition from traditional methods.
---
Ownership Overview
26.62% Insiders
2.22% Mutual Funds
25.98% Other Institutional Investors
43.27% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
RPID FAQ
What was Rapid Micro Biosystems’s price range in the past 12 months?
Rapid Micro Biosystems lowest stock price was $0.58 and its highest was $4.04 in the past 12 months.
What is Rapid Micro Biosystems’s market cap?
Rapid Micro Biosystems’s market cap is $114.14M.
When is Rapid Micro Biosystems’s upcoming earnings report date?
Rapid Micro Biosystems’s upcoming earnings report date is May 02, 2025 which is in 29 days.
How were Rapid Micro Biosystems’s earnings last quarter?
Rapid Micro Biosystems released its earnings results on Feb 28, 2025. The company reported -$0.22 earnings per share for the quarter, beating the consensus estimate of -$0.23 by $0.01.
Is Rapid Micro Biosystems overvalued?
According to Wall Street analysts Rapid Micro Biosystems’s price is currently Undervalued.
Does Rapid Micro Biosystems pay dividends?
Rapid Micro Biosystems does not currently pay dividends.
What is Rapid Micro Biosystems’s EPS estimate?
Rapid Micro Biosystems’s EPS estimate is -0.25.
How many shares outstanding does Rapid Micro Biosystems have?
Rapid Micro Biosystems has 38,737,160 shares outstanding.
What happened to Rapid Micro Biosystems’s price movement after its last earnings report?
Rapid Micro Biosystems reported an EPS of -$0.22 in its last earnings report, beating expectations of -$0.23. Following the earnings report the stock price went down -7.855%.
Which hedge fund is a major shareholder of Rapid Micro Biosystems?
Currently, no hedge funds are holding shares in RPID
---
Rapid Micro Biosystems Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.00 (206.51% Upside)
$8.00 (206.51% Upside)
Blogger Sentiment
Bullish
RPID Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 548.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $20.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 0.7%
Last 30 Days ▼ 0.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
171.87%
12-Months-Change
Fundamentals
Return on Equity
-48.50%
Trailing 12-Months
Asset Growth
-31.57%
Trailing 12-Months
Company Description
Rapid Micro Biosystems
Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.
---
RPID Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue growth and strategic partnerships aimed at enhancing future performance. However, challenges such as validation decreases and negative product margins remain. The outlook for 2025 is conservative, reflecting ongoing uncertainties.Read More>---
RPID Stock 12 Month Forecast
Average Price Target
$8.00
▲(206.51% Upside)
Technical Analysis
Best Analysts Covering RPID
1 Year
1 Year Success Rate
1/4 ratings generated profit
1 Year Average Return
+4.50%
reiterated a buy rating 11 months ago
Copying Daniel Arias's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of +4.50% per trade.
---